The cAMP Hunter™ Liraglutide Bioassay Kit provides a cell-based solution for liraglutide drug testing and quality control. This qualified bioassay enables precise liraglutide potency measurement and neutralizing antibody detection using CHO-K1 cells overexpressing human GLP-1 receptors. The assay leverages EFC technology for sensitive cAMP detection.
This bioassay kit serves companies developing GLP-1 receptor agonist therapies for diabetes and metabolic disorders. Applications include drug characterization, lot release testing, stability studies, and neutralizing antibody screening. The ready-to-use format accelerates results while ensuring consistency.
This kit has been optimized with Victoza® to meet regulatory requirements, providing validated parameters including accuracy, precision, linearity, and robustness for regulatory submissions and QC programs.